leustroducsin B

from Streptomyces platensis SANK 60191; structure in first source

Also Known As:

LSN B; Octanoic acid, 6-methyl-, 3-(8-(2-aminoethyl)-10-(3-ethyl-3,6-dihydro-6-oxo-2H-pyran-2-yl)-5,8-dihydroxy-7-(phosphonooxy)-1,3,9-decatrienyl)cyclohexyl ester

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Pyrones: 35
      - leustroducsin B: 2

Related Diseases

1.	Thrombocytosis (Thrombocythemia) 01/01/1996 - "This cytokine profile suggests that LSN-B induction of thrombocytosis is mechanistically distinct from other cytokine inducers such as IL-1 or FK-565."
2.	Infections 01/01/1994 - "Treatment with LSN B augmented the host resistance to lethal infection of E. "
3.	Bacterial Infections (Bacterial Infection) 01/01/1994 - "Augmentation of host resistance against bacterial infection by treatment with leustroducsin B, a new CSF inducer."

Related Drugs and Biologics

1.	Cytokines
2.	Interleukin-1 (Interleukin 1)
3.	heptanoyl- gamma- D- glutamyl- L- meso- diaminopimelyl- D- alanine